139 related articles for article (PubMed ID: 22579651)
1. Blocking p38/ERK crosstalk affects colorectal cancer growth by inducing apoptosis in vitro and in preclinical mouse models.
Chiacchiera F; Grossi V; Cappellari M; Peserico A; Simonatto M; Germani A; Russo S; Moyer MP; Resta N; Murzilli S; Simone C
Cancer Lett; 2012 Nov; 324(1):98-108. PubMed ID: 22579651
[TBL] [Abstract][Full Text] [Related]
2. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells.
Zhan Y; Gong K; Chen C; Wang H; Li W
Free Radic Biol Med; 2012 Aug; 53(3):532-43. PubMed ID: 22634147
[TBL] [Abstract][Full Text] [Related]
3. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription.
Chiacchiera F; Matrone A; Ferrari E; Ingravallo G; Lo Sasso G; Murzilli S; Petruzzelli M; Salvatore L; Moschetta A; Simone C
Cell Death Differ; 2009 Sep; 16(9):1203-14. PubMed ID: 19343039
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A.
Germani A; Matrone A; Grossi V; Peserico A; Sanese P; Liuzzi M; Palermo R; Murzilli S; Campese AF; Ingravallo G; Canettieri G; Tezil T; Simone C
Cancer Lett; 2014 Mar; 344(1):110-118. PubMed ID: 24215867
[TBL] [Abstract][Full Text] [Related]
5. Importance of the stress kinase p38alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells.
Warfel NA; Lepper ER; Zhang C; Figg WD; Dennis PA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3502-9. PubMed ID: 16740776
[TBL] [Abstract][Full Text] [Related]
6. p38 MAPK regulates phosphorylation of Bad via PP2A-dependent suppression of the MEK1/2-ERK1/2 survival pathway in TNF-alpha induced endothelial apoptosis.
Grethe S; Pörn-Ares MI
Cell Signal; 2006 Apr; 18(4):531-40. PubMed ID: 15972258
[TBL] [Abstract][Full Text] [Related]
7. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
[TBL] [Abstract][Full Text] [Related]
8. Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer.
Pitts TM; Newton TP; Bradshaw-Pierce EL; Addison R; Arcaroli JJ; Klauck PJ; Bagby SM; Hyatt SL; Purkey A; Tentler JJ; Tan AC; Messersmith WA; Eckhardt SG; Leong S
PLoS One; 2014; 9(11):e113037. PubMed ID: 25401499
[TBL] [Abstract][Full Text] [Related]
9. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
[TBL] [Abstract][Full Text] [Related]
10. Targeting cap-dependent translation to inhibit Chikungunya virus replication: selectivity of p38 MAPK inhibitors to virus-infected cells due to autophagy-mediated down regulation of phospho-ERK.
Mudaliar P; Pradeep P; Abraham R; Sreekumar E
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34328830
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells.
Abdollahi T; Robertson NM; Abdollahi A; Litwack G
Apoptosis; 2005 Dec; 10(6):1383-93. PubMed ID: 16215677
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.
van Houdt WJ; de Bruijn MT; Emmink BL; Raats D; Hoogwater FJ; Borel Rinkes IH; Kranenburg O
Cell Oncol; 2010 Jan; 32(4):245-57. PubMed ID: 20413844
[TBL] [Abstract][Full Text] [Related]
13. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
Ye J; Li A; Liu Q; Wang X; Zhou J
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1042-8. PubMed ID: 16445569
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer.
Pek M; Yatim SMJM; Chen Y; Li J; Gong M; Jiang X; Zhang F; Zheng J; Wu X; Yu Q
Oncogene; 2017 Aug; 36(35):4975-4986. PubMed ID: 28459468
[TBL] [Abstract][Full Text] [Related]
16. p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes.
Lee SK; Jang HJ; Lee HJ; Lee J; Jeon BH; Jun CD; Lee SK; Kim EC
Life Sci; 2006 Sep; 79(15):1419-27. PubMed ID: 16697418
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models.
Lee MS; Helms TL; Feng N; Gay J; Chang QE; Tian F; Wu JY; Toniatti C; Heffernan TP; Powis G; Kwong LN; Kopetz S
Oncotarget; 2016 Jun; 7(26):39595-39608. PubMed ID: 27167191
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of linc-UFC1 suppresses proliferation and induces apoptosis of colorectal cancer.
Yu T; Shan TD; Li JY; Huang CZ; Wang SY; Ouyang H; Lu XJ; Xu JH; Zhong W; Chen QK
Cell Death Dis; 2016 May; 7(5):e2228. PubMed ID: 27195675
[TBL] [Abstract][Full Text] [Related]
19. BRAF V600E inhibition stimulates AMP-activated protein kinase-mediated autophagy in colorectal cancer cells.
Sueda T; Sakai D; Kawamoto K; Konno M; Nishida N; Koseki J; Colvin H; Takahashi H; Haraguchi N; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Satoh T; Doki Y; Mori M; Ishii H
Sci Rep; 2016 Jan; 6():18949. PubMed ID: 26750638
[TBL] [Abstract][Full Text] [Related]
20. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
